Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP198967.RACsxQi73s_zj7qa92vDiLMthkLUrcJo5jBd7ZLN0bxkw130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP198967.RACsxQi73s_zj7qa92vDiLMthkLUrcJo5jBd7ZLN0bxkw130_provenance.
• NP330403.RAn3YsHpbe8rf93WGIxmWzvf_aa9UGB9WpoLW_irHOJnM130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330403.RAn3YsHpbe8rf93WGIxmWzvf_aa9UGB9WpoLW_irHOJnM130_provenance.
• NP183592.RAin-ArMRr6XzrvR8Qn6Rtw_kvbPg_aJFYEnx7Awc8ST0130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183592.RAin-ArMRr6XzrvR8Qn6Rtw_kvbPg_aJFYEnx7Awc8ST0130_provenance.
• NP710761.RAt40OO-KiHP0ckRmfKHGAxUW2t350luAYRYOT1SOIUxk130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710761.RAt40OO-KiHP0ckRmfKHGAxUW2t350luAYRYOT1SOIUxk130_provenance.
• NP722963.RAuYrwWqMcwyXivi0lDHUw_wJvsLPgWaY_0Po5hUY_4s0130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722963.RAuYrwWqMcwyXivi0lDHUw_wJvsLPgWaY_0Po5hUY_4s0130_provenance.
• NP277079.RANWgYxCP2hDUI1HjsTAeoUrjiF83IMOfafuVECCkmZCU130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP277079.RANWgYxCP2hDUI1HjsTAeoUrjiF83IMOfafuVECCkmZCU130_provenance.
• NP655434.RAwO-Rd4KmWGAJJoKIIHC_p18MSPPErNI1O7r01riJhkA130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655434.RAwO-Rd4KmWGAJJoKIIHC_p18MSPPErNI1O7r01riJhkA130_provenance.
• assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP547503.RAenxVB6bXcZV1hXlYT-VQJ_yi64G_rzAXgTJlK8eFhdQ130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547503.RAenxVB6bXcZV1hXlYT-VQJ_yi64G_rzAXgTJlK8eFhdQ130_provenance.
• NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_provenance.
• NP547500.RAiILlffygX5TTHLUyFVQGvm8F15xy0lm_1c0aCnYHyXw130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547500.RAiILlffygX5TTHLUyFVQGvm8F15xy0lm_1c0aCnYHyXw130_provenance.
• NP547501.RAkMLsu4ewNBuxuW2VKYREERyX4xDrFaDxljRohj7L5xs130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547501.RAkMLsu4ewNBuxuW2VKYREERyX4xDrFaDxljRohj7L5xs130_provenance.
• NP547502.RAgRmWqJbOm7i28zKPuQGD_9EMDUaEpFFHxEEHMTFlgd0130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547502.RAgRmWqJbOm7i28zKPuQGD_9EMDUaEpFFHxEEHMTFlgd0130_provenance.
• NP306240.RA3Cgjk9dPdkuRHahwG0-xnv7jAPAzjyqOr2YRngPFd6I130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306240.RA3Cgjk9dPdkuRHahwG0-xnv7jAPAzjyqOr2YRngPFd6I130_provenance.
• NP547504.RAGDvD2HxJ44K1jSNb6A0PXzJsS78dthsG7VpLzJ8edoM130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547504.RAGDvD2HxJ44K1jSNb6A0PXzJsS78dthsG7VpLzJ8edoM130_provenance.
• NP935940.RA4s9L-3DoDHsQ4HjN08-gy9p2r85mglN37ePWGqvrDNA130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP935940.RA4s9L-3DoDHsQ4HjN08-gy9p2r85mglN37ePWGqvrDNA130_provenance.
• NP935951.RA72r_CDzXc1FEIl0jbUdc0IvsTUf3CtgB-mbwiI2qZv4130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP935951.RA72r_CDzXc1FEIl0jbUdc0IvsTUf3CtgB-mbwiI2qZv4130_provenance.
• NP547505.RA0GX6O92bH1H_KvdOvPKl-5oDSJnM5zGEnODuwpvpmH4130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547505.RA0GX6O92bH1H_KvdOvPKl-5oDSJnM5zGEnODuwpvpmH4130_provenance.